GlassScriptPhysician profile
Scott David Lundy
NPI 1295129831
$8,682.13
in general payments reported to CMS, 2019-2025
9 companies · $556 in 2025
The $556 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $89.19 · 2021: $1,623 · 2022: $3,321 · 2023: $1,112 · 2024: $812 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,479.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,820.40 | 2019-2025 | Ams 700, Axonics |
| Coloplast Corp | $2,783.96 | 2021-2025 | Titan |
| Antares Pharma, INC. | $530.49 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Tolmar, INC. | $161.54 | 2025 | Jatenzo |
| Endo Pharmaceuticals INC. | $132.56 | 2022 | |
| Innovation Technologies INC | $114.93 | 2023 | Irrisept |
| Astellas Pharma US INC | $99.95 | 2021 | |
| Convatec INC. | $20.83 | 2022 | |
| Metuchen Pharmaceuticals | $17.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lundy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.